— Mark Adams is stepping down as chief operating officer of Adaptive Biotechnologies, the company said today in a regulatory filing. Adams joined the Seattle-based biotech giant more than three… Read More
Adaptive Biotechnologies announced its first quarter earnings Wednesday, two months after laying off 12% of its workforce. The public Seattle company pulled in $38.6 million in revenue, up 0.5% from… Read More
2020 was a big year for big tech on Wall Street. Despite parts of the economy shuttering due to COVID-19, many stocks soared. The technology sector led the way, with… Read More
A novel effort from Microsoft and Adaptive Biotechnologies to diagnose multiple diseases from a single blood test is a data challenge on the scale of Google search. “Google categorized the… Read More
Adaptive Biotechnologies, a high-flying startup that makes technology to read the human immune system, has officially filed to go public and seeks to raise $230 million from investors. Founded in… Read More
Adaptive Biotechnologies, the heavily-funded Seattle bioinformatics company, today announced that Diego Miralles will become the president of a new division of the company called Adaptive Therapeutics. Miralles will work to build out the… Read More
In the largest venture capital round in Washington state so far this year, Adaptive Biotechnologies has scored $195 million in fresh funding that the Seattle company said it will use… Read More
—Telecommunications entrepreneur Vern Fotheringham has been named CEO of Leosat, an Arlington, Virginia-based company developing a constellation of low-earth orbit satellites. Fotheringham, a veteran of the telecom business who previously… Read More